AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $528 | -99.9% | 72,334 | 0.0% | 0.04% | +14.7% |
Q3 2022 | $501,000 | -1.0% | 72,334 | 0.0% | 0.03% | -5.6% |
Q2 2022 | $506,000 | -15.4% | 72,334 | 0.0% | 0.04% | -7.7% |
Q1 2022 | $598,000 | -23.4% | 72,334 | 0.0% | 0.04% | -36.1% |
Q4 2021 | $781,000 | -10.3% | 72,334 | 0.0% | 0.06% | -31.5% |
Q3 2021 | $871,000 | -7.3% | 72,334 | -6.7% | 0.09% | +2.3% |
Q2 2021 | $940,000 | -13.0% | 77,496 | 0.0% | 0.09% | -17.9% |
Q1 2021 | $1,080,000 | +9.9% | 77,496 | +11.6% | 0.11% | -20.9% |
Q4 2020 | $983,000 | +14.6% | 69,437 | 0.0% | 0.13% | -28.0% |
Q3 2020 | $858,000 | – | 69,437 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |